Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

We analyzed the utility of Revised International staging system (RISS) in an unselected cohort of newly diagnosed multiple myeloma (NDMM; cohort 1), and relapsed/refractory multiple myeloma (RRMM; cohort 2) patients. Cohort 1 included 1900 patients seen within 90 days of diagnosis, from 2005 to 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, N, Rajkumar, S V, LaPlant, B, Pettinger, A, Lacy, M Q, Dispenzieri, A, Buadi, F K, Gertz, M A, Hayman, S R, Leung, N, Go, R S, Dingli, D, Kapoor, P, Lin, Y, Hwa, Y L, Fonder, A L, Hobbs, M A, Zeldenrust, S R, Lust, J A, Gonsalves, W I, Russell, S J, Kumar, S K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386331/
https://www.ncbi.nlm.nih.gov/pubmed/28211889
http://dx.doi.org/10.1038/bcj.2017.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386331/
https://www.ncbi.nlm.nih.gov/pubmed/28211889
http://dx.doi.org/10.1038/bcj.2017.13

Ejemplares similares